Skip to content
Plateltex · PRP / Platelet gel

Chronic and acute wounds

Wound care contexts including diabetic foot ulcers and pressure injuries.

Chronic and acute wounds · Illustrative application image
Illustrative application image
Scientific background

Platelet-derived components and wound healing

Knighton and colleagues’ studies in the 1980s are early scientific contributions to understanding platelet-derived components in wound healing. These historical studies concern broader platelet-based approaches and should not be treated as direct evidence for Plateltex across every chronic wound type.

  • Annals of Surgery, 1982; 196:379–388
  • Annals of Surgery, 1986; 204:322–330
Clinical context

Which wound types are discussed?

The supplied Plateltex material discusses pressure injuries, diabetic ulcers and diabetic foot wounds, post-traumatic lesions, vascular ulcers and spider-bite lesions. Wound cause, circulation, signs of infection and current care must be assessed before considering a biological approach.

  • Pressure injuries
  • Diabetic ulcers and diabetic foot wounds
  • Post-traumatic lesions
  • Vascular ulcers
  • Spider-bite lesions
Care approach

A complementary approach for resistant wounds

Autologous platelet gel may be considered through clinical assessment for wounds that do not heal despite conventional local care and treatment of underlying causes. It does not replace standard wound care or cause-directed treatment. Suitability depends on the product instructions and the patient’s clinical condition.

Multiple factors

Assess the causes behind the wound

Chronic wounds are often associated with multiple factors. Ischaemia, metabolic disorders, bacterial contamination or infection, and nutritional deficiencies can affect healing. A care plan requires appropriate assessment and management of these factors.

  • Circulation and ischaemia
  • Metabolic status
  • Contamination and infection
  • Nutritional status
Outcome monitoring

Wound closure and changes in size

Changes in wound area, closure and healing time are monitored against baseline measurements. Response varies by wound type, underlying causes and care conditions; a single overall success rate does not represent different patient populations.

  • Baseline wound size
  • Change in wound area
  • Complete closure
  • Follow-up duration and care conditions
Neuroischaemic diabetic ulcer at day 0 and day 21
Figure 1. Neuroischaemic diabetic ulcer at baseline (day 0) and day 21. This case does not establish a closure timeline for other wounds. Source printed on the figure: piaghedadecubito.it; supplied by Nevosa.

Request information for your application area